These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8720977)

  • 41. Expression of pS2 protein in breast cancer.
    Crombach G; Ingenhorst A; Göhring UJ; Scharl A; Neuhaus W; Möbus V; Schaeffer HJ
    Arch Gynecol Obstet; 1993; 253(4):183-92. PubMed ID: 8161252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.
    Rio MC; Bellocq JP; Daniel JY; Tomasetto C; Lathe R; Chenard MP; Batzenschlager A; Chambon P
    Science; 1988 Aug; 241(4866):705-8. PubMed ID: 3041593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen-dependent protein in cells of mammary ductal carcinoma. Analysis of five-year course of the disease.
    Surowiak P; Dziegiel P; Zabel M; Matkowski R; Kornafel J
    Folia Histochem Cytobiol; 2001; 39(2):143-4. PubMed ID: 11374797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer.
    Jansen RL; Hupperets PS; Arends JW; Joosten-Achjanie SR; Volovics A; Hillen HF; Schouten HC
    Anticancer Res; 1998; 18(1B):577-82. PubMed ID: 9568180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer.
    Cappelletti V; Coradini D; Scanziani E; Benini E; Silvestrini R; Di Fronzo G
    Eur J Cancer; 1992; 28A(8-9):1315-8. PubMed ID: 1515241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival.
    Thor AD; Koerner FC; Edgerton SM; Wood WC; Stracher MA; Schwartz LH
    Breast Cancer Res Treat; 1992; 21(2):111-9. PubMed ID: 1627814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of cathepsin-D and pS2 protein levels in human breast cancer cell lines.
    Cappelletti V; Fioravanti L; Miodini P; Di Fronzo G
    Tumour Biol; 1996; 17(5):290-8. PubMed ID: 8792855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of the pS2 gene in breast cancer--a comparison of pS2 protein radioimmunoassay and immunohistochemistry.
    Robbins PD; Hähnel E; Sterrett GF; Harvey J; Carrello S; Hähnel R
    Pathology; 1993 Jul; 25(3):255-60. PubMed ID: 8265245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the pS2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns.
    Dookeran KA; Rye PD; Dearing SJ; Walker RA
    J Pathol; 1993 Oct; 171(2):123-9. PubMed ID: 8283349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours.
    Pallud C; Le Doussal V; Pichon MF; Prud'homme JF; Hacene K; Milgrom E
    Histopathology; 1993 Sep; 23(3):249-56. PubMed ID: 8225243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer.
    Foekens JA; van Putten WL; Portengen H; Rodenburg CJ; Reubi JC; Berns PM; Henzen-Logmans SC; van der Burg ME; Alexieva-Figusch J; Klijn JG
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):815-21. PubMed ID: 2178364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Correlation with prognosis and adjuvant hormone therapy.
    Predine J; Spyratos F; Prud'homme JF; Andrieu C; Hacene K; Brunet M; Pallud C; Milgrom E
    Cancer; 1992 Apr; 69(8):2116-23. PubMed ID: 1544118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cysts.
    Dante R; Ribieras S; Baldassini S; Martin V; Benzerara O; Bouteille C; Brémond A; Frappart L; Rio MC; Lasne Y
    Lab Invest; 1994 Aug; 71(2):188-92. PubMed ID: 8078298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of estrogen receptor (ER) and estrogen-dependent pS2 protein expression in cells of mammary ductal carcinoma.
    Surowiak P; Dziegiel P; Zabel M; Matkowski R; Kornafel J
    Folia Histochem Cytobiol; 2001; 39(2):141-2. PubMed ID: 11374796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: inconsistency with their established prognostic significance.
    Ardavanis A; Gerakini F; Amanatidou A; Scorilas A; Pateras C; Garoufali A; Pissakas G; Stravolemos K; Apostolikas N; Yiotis I
    Anticancer Res; 1997; 17(5A):3665-9. PubMed ID: 9413220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of pS2 messenger RNA in gynecological cancers.
    Wysocki SJ; Hahnel E; Masters A; Smith V; McCartney AJ; Hahnel R
    Cancer Res; 1990 Mar; 50(6):1800-2. PubMed ID: 2306733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study on the relationship between PS2 protein expression and prognosis in invasive breast carcinoma].
    Cheng J; Lin H; Liang X
    Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):331-3. PubMed ID: 10374319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Specific expression of human pS2 gene in breast cancer].
    Rio MC; Bellocq JP; Gairard B; Koehl C; Renaud R; Chambon P
    Biochimie; 1988 Jul; 70(7):961-8. PubMed ID: 3145028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of pS2 protein in transitional cell bladder tumours.
    Lipponen PK; Eskelinen MJ
    J Pathol; 1994 Aug; 173(4):327-32. PubMed ID: 7965392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parameters.
    Speiser P; Mayerhofer K; Kucera E; Roch G; Mittelböck M; Gitsch G; Zeillinger R
    Anticancer Res; 1997; 17(1B):679-83. PubMed ID: 9066601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.